April 26, 2018 / 8:53 AM / 5 months ago

BRIEF-Pangen Biotech receives patent

April 26 (Reuters) - Pangen Biotech Inc :

* Says it received patent on April 26, for antibodies cross-reactive to Human and Mouse Sema3A and Uses thereof

* Patent number is 10-2016-0123233

Source text in Korean : goo.gl/9Xu8wm

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below